Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind comparison of four doses of PLA-695 versus naproxen in knee osteoarthritis
2006-002590-44Phase 2Completed
- Sponsor
- Wyeth
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of giripladib in knee osteoarthritis (OA) (4 arms), sponsored by Wyeth. Primary endpoint: WOMAC VAS walking pain (question 1) at week 6. Started Sep 2006; status: completed.
02
Drugs
giripladib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-002590-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002590-44.